Aquatic Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GS
TCM
MAP
PM
EC
DCM
Aquatic Capital Management's LKFT Position: Q2 2026 in Review
Aquatic Capital Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 23% in Q2 2026, selling an estimated $78.1K and leaving 9,109 shares worth $273K. The position accounts for 0.01% of the portfolio, ranked #941.
Aquatic Capital Management first reported a position in LKFT in Q4 2021 and has held it in 16 quarters since. The position peaked at $726K in Q4 2024. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- Aquatic Capital Management held 9,109 shares of Lakefront Biotherapeutics American Depositary Shares worth $273K as of Q2 2026.
- Aquatic Capital Management sold 2,750 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $78.1K.
- Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Aquatic Capital Management's portfolio in Q2 2026, its #941 holding.
- Aquatic Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2021 and has held it in 16 quarters since.
- Aquatic Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $726K in Q4 2024.
- 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.